Andrea Van Beek Invites You to Join The 2025 Virtual Boot Camp
Andrea Van Beek, Board of Directors of Anticoagulation Forum, National Certification Board for Anticoagulation Providers, shared an inviing post on LinkedIn:
”Want to expand your knowledge about all-things anticoagulation – all from the comfort of your couch?!
Join us for our (very popular!) 2 day virtual Boot Camp this fall!
I’ll be giving talks about Warfarin day-to-day management (including some difficult warfarin cases), as well as Shared Decision Making and Patient Education.
You won’t want to miss our daily Chalk Talks – ask the experts all your burning questions.
Register today to reserve your spot!
The 2025 Virtual Boot Camp is now open for registration.
This trusted, expert-led program returns October 17–18 with fresh topics, real-world insights, and 30 days of enduring access to fit any schedule.”
Anticoagulation Forum shared a post on LinkedIn:
‘The 2025 Boot Camp offers:
Comprehensive curriculum covering anticoagulation, disease state, and drug management
Interactive “Chalk Talks” and live Q and As with expert faculty
Designed for pharmacists, physicians, nurses, and trainees
Earn valuable CE credits and practical strategies to bring back to your practice
The registration rate is USD349 for all registrants, and it will remain open until October 18, 2025. Group pricing is available; email [email protected] to inquire.
Whether you are training new clinicians or refreshing your own knowledge, this is a must-attend event for staying current and connected.’
Andrea Van Beek shared an invitation you should not miss. Register Now.
Learn about all the opportunities in the field with Hemostasis Today.
-
Sep 18, 2025, 06:50Fetal Hereditary TTP Featured in NEJM – Senior Author Nishant Rajendra Tiwari
-
Sep 17, 2025, 10:54Mitapivat Boosts ATP in Red Cells: Dr. William Aird on New Hope for Hemolytic Disorder
-
Sep 17, 2025, 08:16Superficial Vein Thrombosis Management: John Fanikos Shares Latest Review
-
Sep 17, 2025, 07:00Maha Othman - ''BIC 2025 is Without a Doubt a Remarkable Scientific Event — and I’m Excited for What Lies Ahead!''
-
Sep 16, 2025, 11:17Glenn Pierce: WHO Issues a Biannual Essential Medicines List
-
Sep 18, 2025, 07:00Rishabh Singh on NEJM Letter: FVIII Aurora Mutation Shows Increased Activity and Reduced APC Response
-
Sep 18, 2025, 02:25Flora Peyvandi Highlights 'Inflammatory Memory of Stem Cells' – New Insights for Hematologic Diseases
-
Sep 17, 2025, 16:32Endovascular Today: Dr. Eric Secemsky Analyzes Impact of Paclitaxel Pause on Peripheral Artery Disease Care
-
Sep 17, 2025, 16:28Haemnet Showcases Research on Severe Haemophilia A Patients Adapting to Emicizumab Therapy
-
Sep 17, 2025, 16:19Todd Villines: Coronary Artery Disease - A BIG Movement to Change
-
Sep 16, 2025, 14:59A New Era in Antiplatelet Therapy for CABG?
-
Sep 16, 2025, 07:44Artificial Blood Breakthrough in Japan: Long Shelf Life, No Type Matching, and a Purple Future
-
Sep 16, 2025, 02:44Wolfgang Miesbach Highlights First Inhibitor Case After Hemophilia A Gene Therapy (Giroctocogene Fitelparvovec)
-
Sep 12, 2025, 15:21Christian Schäfer: INR Self-Management Has Officially Been Given Class IA Status in the ESC Guidelines
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 18, 2025, 06:34'A New Era in Mechanical Thrombectomy?' – Sripal Bangalore Highlights SYMPHONY-PE IDE Study
-
Sep 17, 2025, 10:49Living with Glanzmann Thrombasthenia․ Eliza VanZweden’s Story of Resilience and Advocacy
-
Sep 17, 2025, 10:22Abdul Mannan: Turning Medical Podcasts into Active Learning with Structured Tools
-
Sep 17, 2025, 09:43Global Blood Supply Under Threat: David McIntosh Calls for Action to Support Transfusion Services
-
Sep 17, 2025, 09:08Coronary Arteries, Pericardial Cavity, and the Hidden Danger of Cardiac Tamponade During PCI-By Ahmed Ata